144 related articles for article (PubMed ID: 2625032)
1. Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
Montaña E; Goday A; Rosel P; Casamitjana R; Soler J; Gomis R
Diabetes Res; 1989 Aug; 11(4):167-71. PubMed ID: 2625032
[TBL] [Abstract][Full Text] [Related]
2. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
[TBL] [Abstract][Full Text] [Related]
3. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
Elamin A; Omer MI; Tuvemo T
Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
[TBL] [Abstract][Full Text] [Related]
4. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
[TBL] [Abstract][Full Text] [Related]
5. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.
Decochez K; Keymeulen B; Somers G; Dorchy H; De Leeuw IH; Mathieu C; Rottiers R; Winnock F; ver Elst K; Weets I; Kaufman L; Pipeleers DG; Gorus FK;
Diabetes Care; 2000 Aug; 23(8):1072-8. PubMed ID: 10937500
[TBL] [Abstract][Full Text] [Related]
6. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
Samuelsson U; Ludvigsson J; Sundkvist G
Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
[TBL] [Abstract][Full Text] [Related]
7. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
[TBL] [Abstract][Full Text] [Related]
8. Serial changes in the prevalence of islet cell antibodies and islet cell antibody titer in children with IDDM of abrupt or slow onset.
Urakami T; Miyamoto Y; Matsunaga H; Owada M; Kitagawa T
Diabetes Care; 1995 Aug; 18(8):1095-9. PubMed ID: 7587843
[TBL] [Abstract][Full Text] [Related]
9. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
10. Natural history of islet cell antibodies during the clinical period of type 1 diabetes. High titres at diagnosis are associated with longer persistence.
Goday A; Fernandez J; Gonzalez-Clemente JM; Ferrer J; Usach E; Gomis R; Vilardell E
Diabetes Res; 1991 Aug; 17(4):169-74. PubMed ID: 1823637
[TBL] [Abstract][Full Text] [Related]
11. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
[TBL] [Abstract][Full Text] [Related]
12. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease.
Karjalainen JK
Diabetes; 1990 Sep; 39(9):1144-50. PubMed ID: 2200731
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
[TBL] [Abstract][Full Text] [Related]
14. Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.
Jennings AM; Spencer KM; Dean BM; Wilson RM; Bottazzo GF; Ward JD
Diabet Med; 1989 Jul; 6(5):434-9. PubMed ID: 2527682
[TBL] [Abstract][Full Text] [Related]
15. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
16. Relation between course of disease in type 1 diabetes and islet cell antibodies.
Zamaklar M; Jotic A; Lalic N; Lalic K; Rajkovic N; Milicic T
Ann N Y Acad Sci; 2002 Apr; 958():251-3. PubMed ID: 12021117
[TBL] [Abstract][Full Text] [Related]
17. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.
Sundkvist G; Hagopian WA; Landin-Olsson M; Lernmark A; Ohlsson L; Ericsson C; Ahlmén J
J Clin Endocrinol Metab; 1994 May; 78(5):1159-65. PubMed ID: 8175973
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.
Martino GV; Tappaz ML; Braghi S; Dozio N; Canal N; Pozza G; Bottazzo GF; Grimaldi LM; Bosi E
J Autoimmun; 1991 Dec; 4(6):915-23. PubMed ID: 1812896
[TBL] [Abstract][Full Text] [Related]
19. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
Mustonen A; Knip M; Akerblom HK
Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
[TBL] [Abstract][Full Text] [Related]
20. Relationship of islet cell and islet cell surface antibodies to the presentation and early course of IDDM in childhood.
Daneman D; Sochett E; Pak CY; Yoon JW
Diabetes Res Clin Pract; 1988 Jan; 4(2):127-32. PubMed ID: 3277828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
